A unique case of diffuse retinal ischemia following intravenous abuse of crushed extended-release oxymorphone hydrochloride (Opana ER) is reported. This case highlights a potentially blinding condition as a result of retinal vascular endothelial injury following intravenous abuse of a medication intended for oral use.
Article InformationCorresponding Author: Edward F. Cherney, MD, Vanderbilt Eye Institute, 2311 Pierce Ave, Nashville, TN 37232 (email@example.com).
Study concept and design: Shah, Cherney.
Acquisition, analysis, or interpretation of data: Shah, Cherney.
Drafting of the manuscript: Shah.
Critical revision of the manuscript for important intellectual content: Shah, Cherney.
Administrative, technical, or material support: Shah, Cherney.
Study supervision: Cherney.
Conflict of Interest Disclosures: None reported.